Neuromuscular toxicity in nephrotic patients treated with fluvastatin. 2002

Sanaa Gazarin, and Hassan Abd-El-Hady, and Osama Gheith, and Mahmoud Rasem, and Mohamed Saad, and Kefaya El-Sayed, and Mohamed Sobh, and Galal Amer
Department of Internal Medicine, Urology & Nephrology Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

Nephrotic dyslipidemia is a risk factor for the development of systemic atherosclerosis, and may aggravate glomerulosclerosis and enhance progression of glomerular disease. The greatest and most consistent reductions in LDL-cholesterol are achieved with HMG-CoA reductase inhibitors but their efficacy and safety in long-term therapy need to be evaluated. In this study, we gave fluvastatin to 21 nephrotic patients and followed then up clinically, neurophysiologically and by laboratory tests. There was an improvement in the lipogram, with reductions of triglycerides (TG) (33%) and LDL (35%) at three months. There was no clinical manifestation of myopathy and CPK was normal. Electromyographic data showed significant decreases in the amplitude and duration of motor unit action potentials in the proximal muscles with statin therapy, but these changes did not amount to classic myopathy. We conclude that fluvastatin is a safe drug for long-term use in dyslipidemic nephrotic patients. However, we suggest further studies to verify whether the early electromyography (EMG) changes observed in this study may progress or not on its longer term use.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004576 Electromyography Recording of the changes in electric potential of muscle by means of surface or needle electrodes. Electromyogram,Surface Electromyography,Electromyograms,Electromyographies,Electromyographies, Surface,Electromyography, Surface,Surface Electromyographies
D005229 Fatty Acids, Monounsaturated Fatty acids which are unsaturated in only one position. Monounsaturated Fatty Acid,Acid, Monounsaturated Fatty,Acids, Monounsaturated Fatty,Fatty Acid, Monounsaturated,Monounsaturated Fatty Acids
D005260 Female Females

Related Publications

Sanaa Gazarin, and Hassan Abd-El-Hady, and Osama Gheith, and Mahmoud Rasem, and Mohamed Saad, and Kefaya El-Sayed, and Mohamed Sobh, and Galal Amer
January 1999, American journal of nephrology,
Sanaa Gazarin, and Hassan Abd-El-Hady, and Osama Gheith, and Mahmoud Rasem, and Mohamed Saad, and Kefaya El-Sayed, and Mohamed Sobh, and Galal Amer
March 1997, Archives of disease in childhood,
Sanaa Gazarin, and Hassan Abd-El-Hady, and Osama Gheith, and Mahmoud Rasem, and Mohamed Saad, and Kefaya El-Sayed, and Mohamed Sobh, and Galal Amer
March 2002, Journal of clinical pharmacology,
Sanaa Gazarin, and Hassan Abd-El-Hady, and Osama Gheith, and Mahmoud Rasem, and Mohamed Saad, and Kefaya El-Sayed, and Mohamed Sobh, and Galal Amer
January 2002, Clinical hemorheology and microcirculation,
Sanaa Gazarin, and Hassan Abd-El-Hady, and Osama Gheith, and Mahmoud Rasem, and Mohamed Saad, and Kefaya El-Sayed, and Mohamed Sobh, and Galal Amer
April 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Sanaa Gazarin, and Hassan Abd-El-Hady, and Osama Gheith, and Mahmoud Rasem, and Mohamed Saad, and Kefaya El-Sayed, and Mohamed Sobh, and Galal Amer
March 1992, Presse medicale (Paris, France : 1983),
Sanaa Gazarin, and Hassan Abd-El-Hady, and Osama Gheith, and Mahmoud Rasem, and Mohamed Saad, and Kefaya El-Sayed, and Mohamed Sobh, and Galal Amer
August 2021, Muscle & nerve,
Sanaa Gazarin, and Hassan Abd-El-Hady, and Osama Gheith, and Mahmoud Rasem, and Mohamed Saad, and Kefaya El-Sayed, and Mohamed Sobh, and Galal Amer
March 2002, Nihon Jinzo Gakkai shi,
Sanaa Gazarin, and Hassan Abd-El-Hady, and Osama Gheith, and Mahmoud Rasem, and Mohamed Saad, and Kefaya El-Sayed, and Mohamed Sobh, and Galal Amer
January 2015, Klinicheskaia meditsina,
Sanaa Gazarin, and Hassan Abd-El-Hady, and Osama Gheith, and Mahmoud Rasem, and Mohamed Saad, and Kefaya El-Sayed, and Mohamed Sobh, and Galal Amer
April 1992, Journal of autoimmunity,
Copied contents to your clipboard!